Obesity, glucose intolerance, and hypertension in childhood are strongly linked with premature death from endogenous causes in young adulthood and middle age, according to the results of a new epidemiological study….
Read More »INGAP (Exsulin™) Study to Regenerate Beta Cells Begins
A clinical trial of Exsulin, an innovative new treatment that targets the underlying cause of Type 1 diabetes offering hope for those with Type 1 diabetes, has begun at the McGill University Health Centre (MUHC), Montreal….
Read More »Metformin XR Helps Overweight Teens Lose Weight
According to a study, metformin XR, a medication prescribed to treat patients with Type 2 diabetes, helps adolescents lose weight when used in combination with a program encouraging increased physical activity and controlled diet….
Read More »Pay-for-Performance Improves Patient Care Outcomes for Diabetes
Measures of quality of care and clinical outcomes improved significantly when diabetic patients in a large private health plan were treated by physicians receiving pay-for-performance incentives, researchers said….
Read More »Monitoring Helps Stop Drug-Associated Hyperkalemia Events in Diabetics
Potassium monitoring can help prevent drug-associated hyperkalemia events in patients with diabetes, according to a report.…
Read More »Diabetes Tied to Poor Impulse Control
Patients with newly diagnosed Type 2 diabetes were significantly more likely to show poor impulse control in psychological testing than healthy people, researchers said. The findings could help explain why diabetic patients find it difficult to make the recommended lifestyle adjustments such as avoiding high-fat foods and maintaining daily exercise.…
Read More »Prevalence of Childhood Chronic Health Conditions Increases
The rate of chronic health conditions among children in the U.S. increased from 12.8 percent in 1994 to 26.6 percent in 2006, for conditions such as obesity, asthma and behavior/learning problems, according to a study….
Read More »FDA Expands Rosuvastatin Use to People with Normal LDL
The FDA has approved the statin for reducing the risk of stroke, myocardial infarction, and revascularization procedures in individuals who have normal low-density lipoprotein (LDL) levels. The new labeling, recommended by an FDA advisory panel late last year, also marks the first time that a drug label will include an …
Read More »Vinegar Decreases Postprandial Hyperglycemia in Patients with Type 1
Vinegar could be easily used as a complementary food (e.g., in a salad dressing) to reduce hyperglycemia….
Read More »Lispro Vs. Detemir in Insulin-Naive Type 2 Diabetes Patients
Lispro comes out ahead with lower A1c results, but….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.